摘要
目的观察恩度联合NP方案(长春瑞宾+顺铂)治疗晚期非小细胞肺癌的近期临床疗效,评价恩度临床应用的安全性和耐受性。方法比较恩度联合NP组(联合化疗组)和NP组(单纯化疗组)疗效。结果联合化疗组有效率为25.58%,单纯化疗组有效率为9.76%,毒副反应主要有白细胞减少、恶心、呕吐、乏力等。结论恩度与NP方案联合应用,能明显提高晚期非小细胞肺癌的有效率,且安全性较好。
Objective To investigate the short-term effects and toxicity of YH-16 combined with NP regimen for NSCLC.Methods The effects of combination chemotherapy group and the pure chemotherapy group were compared.Results The combination chemotherapy group′s efficiency rate was 25.58%,while the pure chemotherapy group was 9.76%.The side effects were neutropenia,nausea and vomiting.Conclusion The combination of YH-16 with NP regimen can improve the efficacy rate of NSCLC obviously.Besides,side effect is less than that of others.
出处
《实用临床医药杂志》
CAS
2011年第13期79-80,共2页
Journal of Clinical Medicine in Practice
关键词
恩度
NP方案
非小细胞肺癌
YH-16
NP regimen
non-small cell lung cancer
